CMS Should Rethink Latest Lab Cut, Revaluation Proposals, Industry Says

CMS’ plans to cut reimbursement to independent labs by 26 percent next year, largely based on a policy to cap at outpatient rates, and to perform a wholesale review and revision of physician fee schedule laboratory payments in the longer term were met with resistance by ACLA, AdvaMed and other industry stakeholders.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Policy & Regulation

More from Medtech Insight